Business Wire

CROMA-PHARMA-GMBH

Share
Croma-Pharma announces submission for their botulinum toxin to treat glabellar (frown) lines to the German authority BfArM

On July the 8th , Croma-Pharma GmbH (Croma) has stated that the company submitted the drug file of its botulinum toxin product to the German authority BfArM. The filing of the dossier stands for the next essential step towards Croma’s complete aesthetic portfolio in Europe, which already comprises of a comprehensive HA filler range, threads, PRP and skincare products.

Croma has licensed the product from the Korean toxin producer Hugel Inc. for Europe and established a joint venture company in 2018 with Hugel, Inc., in order to develop and commercialize Croma’s HA filler products together with Hugel’s botulinum toxin product in the US, Canada, Australia and New Zealand.

The filing to BfArM marks the first milestone in Croma’s approach to a European wide regulatory approval.

“We are pleased to announce that our toxin has finally been submitted – since quite some time hence, a European company will launch a botulinum toxin, which makes us both, happy and proud. Combining our present product and service offering with the last “missing link” will definitely boost our business and will have a feelable impact not only on our marketing and sales approach, but for sure also on our corporate culture.”, CEO Andreas Prinz points out in a first statement.

Croma’s botulinum toxin submission in Europe is based on 2 completed randomized, placebo-controlled Phase III pivotal trials (BLESS I and II) that enrolled a total of 917 subjects in Europe and the US. A third confirmatory pivotal trial to support the US submission (BLESS III) is currently ongoing in sites in Europe and the US and has completed its interim analysis after all 355 patients completed their visits for the primary endpoint.

About Croma-Pharma GmbH
Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company that specializes in the industrial production of hyaluronic acid syringes for the fields of medical aesthetics, ophthalmology and orthopaedics. Croma currently runs 12 international sales companies and distributes its products in more than 70 countries. Within its global sales network, Croma focuses with own branded products on minimally invasive aesthetic medicine. Besides a broad range of HA fillers from the own production site, Croma markets PDO lifting threads, a Platelet Rich Plasma (PRP) system and a personalized skincare technology in its core strategic markets.

About Hugel, Inc:
Established in Korea in 2001, Hugel is a global leader in medical aesthetics providing botulinum toxin formulation BOTULAX / LETYBO, HA filler The CHAEUM / DERMALAX, and derma cosmetic WELLAGE / PR4 brands. Dedicated to provide proven, high quality medical aesthetic solutions that satisfy both consumers’ and practitioners’ needs, Hugel is leading Korean market for both botulinum toxin and HA filler products and is distributing its products to over 40 countries. Visit: www.hugel.co.kr

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Megaport Surpasses 1,000 Enabled Locations Worldwide7.8.2025 22:00:00 CEST | Press release

Megaport now provides access from 10% of all data centres worldwide, making it the world’s leading Network as a Service provider. Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, announced today that it has launched its 1,000th Megaport-enabled location. With this milestone, Megaport now provides access from 10% of all public data centres worldwide, making it the world’s leading vendor-neutral NaaS connectivity platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807394677/en/ With over 1,000 enabled locations, Megaport now provides access from 10% of all data centres worldwide. From its start as a disruptor in the connectivity space, Megaport has now become the go-to solution for IT teams needing fast, flexible, and secure interconnection between cloud services, data centres, and enterprise sites. The Company’s global reach now spans over 160 cities across 26 countrie

Andersen Consulting indgår samarbejdsaftale med Systematix7.8.2025 21:38:00 CEST | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation og cybersikkerhed med tilføjelsen af samarbejdspartneren Systematix, et førende teknologikonsulentfirma, der er kendt for at levere innovative digitale løsninger, der bidrager til operationel effektivitet, vækst og konkurrencemæssige fordele. Systematix blev stiftet i 1975 og tilbyder komplette konsulent- og implementeringstjenester inden for digital transformation, udvikling af virksomhedsapplikationer, ERP, forretningsanalyse, it-strategi og cybersikkerhed. Med hundredvis af erfarne konsulenter og teknologer hjælper Systematix deres kunder med at navigere i komplekse forretningsmæssige udfordringer ved hjælp af nye teknologier og tilbyder skalerbare løsninger til en række robuste brancher, herunder finanssektoren, sundhedsvæsenet, produktionsvirksomheder og organisationer i den offentlige sektor. "I de sidste fem årtier har vi opbygget et omdømme for at levere robuste teknologiløsninger og ressourcer, der h

Lyten to Acquire All Remaining Northvolt Assets in Sweden and Germany7.8.2025 18:24:00 CEST | Press release

Lyten, the global leader in lithium-sulfur batteries, announced it has entered into binding agreements to acquire Northvolt Ett and Ett Expansion, Northvolt Labs, Northvolt Drei, and all remaining Northvolt intellectual property (IP). These newly acquired assets were previously valued at approximately $5B and include 16 GWh of operational battery production capacity and over 15 GWh under construction. Lyten has expressed interest in additionally acquiring Northvolt Six in Quebec, Canada. Lyten plans to restart operations at Northvolt Ett and Northvolt Labs upon close of the transaction, which is being fully funded with equity investment. Lyten, the global leader in lithium-sulfur batteries, announced today that it has entered into a binding agreement to acquire Northvolt’s remaining assets in Sweden and Germany. The acquisition includes Northvolt Ett and Ett Expansion (Skellefteå, Sweden), Northvolt Labs (Västerås, Sweden), and Northvolt Drei (Heide, Germany). Additionally, Lyten is ac

Energy Vault Secures Final FIRB Approval and Completes Acquisition of 125 MW/1,000 MWh Stoney Creek BESS in Australia7.8.2025 15:15:00 CEST | Press release

Stoney Creek represents first acquisition in Australia as part of Energy Vault’s global “Own & Operate” portfolio and reinforces long-term commitment to Australia’s energy transition125 MW/1,000 MWh Stoney Creek BESS set to support grid reliability and flexibility while advancing the energy transition in New South Wales, supported by a 14-year offtake agreementStoney Creek is Energy Vault’s third and largest Energy Storage Asset in the portfolio, following the successful completion of the Cross Trails BESS in Texas and Calistoga Resiliency Center in California, and is expected to deliver ~$30 million in combined annual, recurring EBITDA for the next 15+ years Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault"), a global leader in grid-scale energy storage solutions, today announced it has received Foreign Investment Review Board (FIRB) approval and completed the full acquisition of the Stoney Creek Battery Energy Storage System (BESS) project in Northern New South Wales. The 125

Museum Centre Vapriikki:Ancient DNA Reveals 800-year-old Family Link in Medieval Finland7.8.2025 14:05:00 CEST | Press release

Ancient DNA research led by the Museum Centre Vapriikki in Tampere, Finland, in collaboration with the universities of Turku and Helsinki, has produced new insights into kinship, health, and population continuity in medieval and early modern Finland. Published in the peer-reviewed journal iScience, the research presents results from 25 individuals in Finland – a significant result in a country where acidic soils often lead to poor preservation of bones and genetic material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807066724/en/ The woman’s grave in Vilusenharju, Tampere was discovered in 1962, and the man’s grave in Ristiänmäki, Pälkäne in 1982. Ancient DNA research has now revealed that the deceased were siblings. Illustrations by Veronika Paschenko. Photo by Vapriikki. Researchers successfully recovered DNA from individuals buried between the 12th and 19th centuries at three cemeteries in the Tampere region. The s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye